Our site may be slower due to heavy traffic from automated "bots" and AI crawlers. We're working to fix this.

Carlotta Zampieri

Title(s)Postdoctoral Scholar, Pathology
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. The urokinase receptor/uPAR is a major effector of p53 gain-of-function mutations in gemcitabine-treated pancreatic ductal adenocarcinoma. J Biol Chem. 2025 Sep; 301(9):110561. Zampieri C, Kouhmareh K, Sartipdolagh P, Azmoon P, Klemke RL, Gonias SL. PMID: 40759369; PMCID: PMC12405631.
      View in: PubMed   Mentions:    Fields:    
    2. Selective metabolic regulations by p53 mutant variants in pancreatic cancer. J Exp Clin Cancer Res. 2024 Nov 26; 43(1):310. Caporali S, Butera A, Ruzza A, Zampieri C, Bantula' M, Scharsich S, Ückert AK, Celardo I, Kouzel IU, Leanza L, Gruber A, Montero J, D'Alessandro A, Brunner T, Leist M, Amelio I. PMID: 39587609; PMCID: PMC11590503.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    3. An LRP1-binding motif in cellular prion protein replicates cell-signaling activities of the full-length protein. JCI Insight. 2023 08 08; 8(15). Mantuano E, Zampieri C, Azmoon P, Gunner CB, Heye KR, Gonias SL. PMID: 37368488; PMCID: PMC10445690.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    4. An antibody that targets cell-surface glucose-regulated protein-78 inhibits expression of inflammatory cytokines and plasminogen activator inhibitors by macrophages. J Cell Biochem. 2023 05; 124(5):743-752. Gunner CB, Azmoon P, Mantuano E, Das L, Zampieri C, Pizzo SV, Gonias SL. PMID: 36947703; PMCID: PMC10200756.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    5. p53-driven lipidome influences non-cell-autonomous lysophospholipids in pancreatic cancer. Biol Direct. 2022 03 08; 17(1):6. Butera A, Roy M, Zampieri C, Mammarella E, Panatta E, Melino G, D'Alessandro A, Amelio I. PMID: 35255936; PMCID: PMC8902766.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    6. p53 mutations define the chromatin landscape to confer drug tolerance in pancreatic cancer. Mol Oncol. 2022 03; 16(6):1259-1271. Zampieri C, Panatta E, Corbo V, Mauriello A, Melino G, Amelio I. PMID: 34919788; PMCID: PMC8936522.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    7. Understanding p53 tumour suppressor network. Biol Direct. 2021 08 06; 16(1):14. Panatta E, Zampieri C, Melino G, Amelio I. PMID: 34362419; PMCID: PMC8348811.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    8. NUAK2 and RCan2 participate in the p53 mutant pro-tumorigenic network. Biol Direct. 2021 08 04; 16(1):11. Mammarella E, Zampieri C, Panatta E, Melino G, Amelio I. PMID: 34348766; PMCID: PMC8335924.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimalsCells
    9. Plasminogen Receptors in Human Malignancies: Effects on Prognosis and Feasibility as Targets for Drug Development. Curr Drug Targets. 2020; 21(7):647-656. Gonias SL, Zampieri C. PMID: 31755385.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimals
    10. Fibrinolysis protease receptors promote activation of astrocytes to express pro-inflammatory cytokines. J Neuroinflammation. 2019 Dec 06; 16(1):257. Pontecorvi P, Banki MA, Zampieri C, Zalfa C, Azmoon P, Kounnas MZ, Marchese C, Gonias SL, Mantuano E. PMID: 31810478; PMCID: PMC6896679.
      View in: PubMed   Mentions: 11     Fields:    Translation:AnimalsCells